TRANYLCYPROMINE

TRANYLCYPROMINE was reported 804 times

TRANYLCYPROMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ELECTRONIC CIGARETTE USER 3 0.2000
1 SUGGESTIBILITY 1 0.2000
2 THERAPEUTIC DRUG MONITORING ANALYSIS INCORRECTLY PERFORMED 5 0.0526
3 PLACENTAL INFARCTION 11 0.0493
4 ATRIOVENTRICULAR SEPTAL DEFECT 23 0.0489
5 PHALANGEAL HYPOPLASIA 3 0.0423
6 JAW CLICKING 7 0.0329
7 DYSSOMNIA 6 0.0312
8 PSYCHOGENIC PAIN DISORDER 3 0.0291
9 HYPERTELORISM OF ORBIT 12 0.0287
10 CENTRAL VENOUS PRESSURE DECREASED 1 0.0286
11 FEEDING INTOLERANCE 8 0.0177
12 ANTIDEPRESSANT DISCONTINUATION SYNDROME 3 0.0143
13 DIET NONCOMPLIANCE 5 0.0136
14 CRANIOSYNOSTOSIS 10 0.0115
15 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 11 0.0102
16 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 5 0.0100
17 DYSMORPHISM 22 0.0093
18 DECEREBRATION 1 0.0088
19 LIMB ASYMMETRY 6 0.0078
20 CONGENITAL EYELID MALFORMATION 1 0.0078
21 HYPERTENSIVE EMERGENCY 9 0.0076
22 MYOFASCIAL PAIN SYNDROME 5 0.0070
23 UNRESPONSIVE TO PAIN STIMULI 1 0.0070
24 ELEVATED MOOD 3 0.0069
25 SUBCHORIONIC HAEMORRHAGE 1 0.0068
26 FEAR-RELATED AVOIDANCE OF ACTIVITIES 1 0.0066
27 ANOMALY OF EXTERNAL EAR CONGENITAL 2 0.0063
28 MICROGNATHIA 3 0.0060
29 HETEROTAXIA 1 0.0060
30 INTRUSIVE THOUGHTS 7 0.0059
31 CONGENITAL CORONARY ARTERY MALFORMATION 1 0.0059
32 HIGH ARCHED PALATE 1 0.0058
33 POST LAMINECTOMY SYNDROME 1 0.0058
34 PULMONARY MALFORMATION 2 0.0057
35 ARNOLD-CHIARI MALFORMATION 5 0.0052
36 BRACHYDACTYLY 1 0.0051
37 POTENTIATING DRUG INTERACTION 15 0.0045
38 CREATININE RENAL CLEARANCE ABNORMAL 2 0.0043
39 ILLUSION 7 0.0042
40 VITAMIN B6 DECREASED 1 0.0039
41 SUPERFICIAL VEIN PROMINENCE 1 0.0039
42 CONGENITAL NOSE MALFORMATION 2 0.0038
43 CONGENITAL EYE DISORDER 1 0.0037
44 CONVERSION DISORDER 7 0.0036
45 VASCULAR ENCEPHALOPATHY 1 0.0035
46 MERYCISM 1 0.0035
47 AKINESIA 7 0.0034
48 EXPOSURE DURING BREAST FEEDING 11 0.0033
49 DRUG DOSE TITRATION NOT PERFORMED 6 0.0033
50 EXTENSOR PLANTAR RESPONSE 3 0.0033
51 FOETAL HEART RATE ABNORMAL 3 0.0032
52 BUNDLE BRANCH BLOCK 3 0.0032
53 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
54 DEAFNESS NEUROSENSORY 10 0.0030
55 HERBAL INTERACTION 1 0.0028
56 LABELLED DRUG-DRUG INTERACTION ISSUE 4 0.0028
57 KERATOCONJUNCTIVITIS SICCA 1 0.0027
58 NOSE DEFORMITY 1 0.0027
59 YAWNING 7 0.0026
60 ATROPHY 5 0.0026
61 JOINT HYPEREXTENSION 1 0.0026
62 BLUE TOE SYNDROME 1 0.0026
63 COMPULSIVE SEXUAL BEHAVIOUR 2 0.0025
64 PROCEDURAL HEADACHE 1 0.0024
65 LOW SET EARS 1 0.0024
66 CONGENITAL CARDIOVASCULAR ANOMALY 2 0.0024
67 CORONARY ARTERY ATHEROSCLEROSIS 1 0.0024
68 SLOW RESPONSE TO STIMULI 3 0.0023
69 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 5 0.0022
70 EAR MALFORMATION 1 0.0022
71 HAEMORRHAGE IN PREGNANCY 3 0.0021
72 HYPERTENSIVE CRISIS 23 0.0021
73 HYPERMOBILITY SYNDROME 1 0.0020
74 PO2 INCREASED 1 0.0020
75 GENITAL HERPES 3 0.0020
76 FOETAL DEATH 10 0.0019
77 SOMATIC SYMPTOM DISORDER 2 0.0019
78 OPTIC ATROPHY 3 0.0018
79 HYPERTHERMIA 14 0.0018
80 PATENT DUCTUS ARTERIOSUS 7 0.0018
81 NEPHROGENIC DIABETES INSIPIDUS 2 0.0017
82 FOOD INTERACTION 3 0.0017
83 SENSE OF OPPRESSION 2 0.0017
84 ANTEROGRADE AMNESIA 1 0.0017
85 NIPPLE DISORDER 1 0.0016
86 NECROTISING COLITIS 2 0.0016
87 CLEFT PALATE 3 0.0016
88 ADJUSTMENT DISORDER 2 0.0015
89 FOETAL GROWTH RESTRICTION 9 0.0015
90 TACHYPHRENIA 5 0.0014
91 BODY TEMPERATURE FLUCTUATION 3 0.0014
92 FOETAL HYPOKINESIA 1 0.0014
93 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 1 0.0014
94 SEROTONIN SYNDROME 27 0.0014
95 EXOPHTHALMOS 3 0.0014
96 BLOOD FOLATE DECREASED 1 0.0014
97 MIDDLE EAR EFFUSION 3 0.0014
98 CEREBRAL VASOCONSTRICTION 1 0.0014
99 NEUROLEPTIC MALIGNANT SYNDROME 16 0.0013
100 BRUXISM 7 0.0013
101 HYDROCEPHALUS 7 0.0013
102 ELECTROMECHANICAL DISSOCIATION 1 0.0013
103 DISINHIBITION 2 0.0012
104 ENDOMETRIAL HYPERPLASIA 1 0.0012
105 PSYCHIATRIC SYMPTOM 9 0.0012
106 ANXIETY DISORDER 4 0.0012
107 DENTAL DISCOMFORT 1 0.0012
108 MYOCARDIAL FIBROSIS 1 0.0012
109 EXPOSURE VIA INGESTION 3 0.0012
110 TONGUE MOVEMENT DISTURBANCE 1 0.0012
111 EYE MOVEMENT DISORDER 8 0.0012
112 PLEUROTHOTONUS 1 0.0011
113 ANORGASMIA 3 0.0011
114 PUPILLARY REFLEX IMPAIRED 2 0.0011
115 PLACENTAL DISORDER 1 0.0011
116 HEPATIC CONGESTION 1 0.0011
117 ALCOHOL INTERACTION 2 0.0010
118 PRINZMETAL ANGINA 1 0.0010
119 DEVELOPMENTAL DELAY 9 0.0010
120 BRAIN HYPOXIA 1 0.0010
121 COMPULSIVE SHOPPING 2 0.0010
122 IMPULSE-CONTROL DISORDER 2 0.0010
123 BRUGADA SYNDROME 1 0.0010
124 COGWHEEL RIGIDITY 1 0.0010
125 NYSTAGMUS 5 0.0009
126 WALKING AID USER 6 0.0009
127 SOCIAL AVOIDANT BEHAVIOUR 5 0.0009
128 DEPRESSIVE SYMPTOM 3 0.0009
129 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
130 HYPERACUSIS 3 0.0008
131 FRACTURED SACRUM 1 0.0008
132 DRUG TOLERANCE 4 0.0008
133 ADENOCARCINOMA PANCREAS 1 0.0008
134 BRADYPHRENIA 5 0.0008
135 ANION GAP INCREASED 1 0.0007
136 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
137 CYSTITIS NONINFECTIVE 1 0.0007
138 CORNEAL ABRASION 1 0.0007
139 CONTRAINDICATED PRODUCT ADMINISTERED 22 0.0007
140 JOINT EFFUSION 5 0.0007
141 ACUTE CORONARY SYNDROME 6 0.0007
142 ATRIAL SEPTAL DEFECT 6 0.0007
143 ABNORMAL SENSATION IN EYE 3 0.0007
144 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
145 APRAXIA 1 0.0007
146 BRAIN HERNIATION 2 0.0007
147 LOSS OF LIBIDO 6 0.0007
148 GASTROINTESTINAL CARCINOMA 6 0.0007
149 HEAT STROKE 1 0.0007
150 ACIDOSIS 5 0.0007
151 SCOLIOSIS 4 0.0006
152 ROSACEA 3 0.0006
153 SUBSTANCE USE 1 0.0006
154 PRESCRIBED OVERDOSE 12 0.0006
155 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
156 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
157 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
158 GAZE PALSY 1 0.0006
159 MYOCLONUS 7 0.0006
160 LAZINESS 1 0.0006
161 BLOOD PH DECREASED 1 0.0006
162 PUPIL FIXED 1 0.0006
163 PANIC REACTION 4 0.0006
164 TIC 3 0.0005
165 HYPOMANIA 2 0.0005
166 IMPULSIVE BEHAVIOUR 2 0.0005
167 SACROILIITIS 1 0.0005
168 NARCOLEPSY 1 0.0005
169 BLOOD BICARBONATE DECREASED 1 0.0005
170 VENTRICULAR SEPTAL DEFECT 3 0.0005
171 INTENTIONAL MISUSE 1 0.0005
172 HYPOREFLEXIA 1 0.0005
173 EXERCISE TOLERANCE DECREASED 3 0.0005
174 DYSTONIA 10 0.0005
175 THROMBOTIC MICROANGIOPATHY 5 0.0005
176 MULTI-ORGAN DISORDER 1 0.0005
177 WRIST FRACTURE 6 0.0005
178 BLOOD PRESSURE FLUCTUATION 12 0.0005
179 LIBIDO INCREASED 1 0.0005
180 SUBSTANCE ABUSE 4 0.0005
181 HYPERAESTHESIA 4 0.0005
182 MICROCYTIC ANAEMIA 1 0.0005
183 MUSCLE TWITCHING 11 0.0005
184 FOETAL DISTRESS SYNDROME 1 0.0005
185 OCULOGYRIC CRISIS 1 0.0005
186 ORTHOSTATIC HYPOTENSION 8 0.0005
187 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
188 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
189 HAEMANGIOMA 1 0.0004
190 MUSCLE TIGHTNESS 7 0.0004
191 DRUG INTERACTION 68 0.0004
192 BURSITIS 5 0.0004
193 MOOD SWINGS 13 0.0004
194 HAEMORRHAGE INTRACRANIAL 6 0.0004
195 ENDODONTIC PROCEDURE 1 0.0004
196 EUPHORIC MOOD 4 0.0004
197 MEAN CELL VOLUME INCREASED 1 0.0004
198 FOOD ALLERGY 3 0.0004
199 FOOD CRAVING 2 0.0004
200 COORDINATION ABNORMAL 5 0.0004
201 APATHY 5 0.0003
202 DISORIENTATION 13 0.0003
203 RESPIRATORY DISTRESS 9 0.0003
204 NERVE COMPRESSION 3 0.0003
205 BRAIN DEATH 1 0.0003
206 NEPHROPATHY 3 0.0003
207 RESPIRATORY RATE DECREASED 1 0.0003
208 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
209 THERAPEUTIC RESPONSE CHANGED 2 0.0003
210 LISTLESS 1 0.0003
211 PANIC ATTACK 11 0.0003
212 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
213 EYELID PTOSIS 3 0.0003
214 SLUGGISHNESS 3 0.0003
215 SUDDEN CARDIAC DEATH 1 0.0003
216 AKATHISIA 4 0.0003
217 HYPERREFLEXIA 1 0.0003
218 DRUG RESISTANCE 7 0.0003
219 ACUTE MYOCARDIAL INFARCTION 8 0.0003
220 ANGER 9 0.0003
221 SUICIDAL IDEATION 24 0.0003
222 PANIC DISORDER 1 0.0003
223 THERAPY PARTIAL RESPONDER 4 0.0003
224 SEXUAL DYSFUNCTION 3 0.0003
225 FEELING COLD 7 0.0003
226 MUSCLE RIGIDITY 3 0.0003
227 HYPERPHAGIA 1 0.0003
228 MIOSIS 2 0.0002
229 TARDIVE DYSKINESIA 7 0.0002
230 NO THERAPEUTIC RESPONSE 3 0.0002
231 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
232 SELF-MEDICATION 1 0.0002
233 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
234 URINARY INCONTINENCE 7 0.0002
235 HYPERPYREXIA 1 0.0002
236 FOETAL EXPOSURE DURING PREGNANCY 19 0.0002
237 ALCOHOLISM 1 0.0002
238 UNRESPONSIVE TO STIMULI 6 0.0002
239 COMPLETED SUICIDE 19 0.0002
240 FEAR 6 0.0002
241 THERAPY NON-RESPONDER 10 0.0002
242 DYSKINESIA 9 0.0002
243 TREATMENT NONCOMPLIANCE 12 0.0002
244 RESPIRATORY ARREST 6 0.0002
245 INTERCEPTED MEDICATION ERROR 1 0.0002
246 SUSPECTED SUICIDE 1 0.0002
247 PHOTOPHOBIA 4 0.0002
248 COLITIS MICROSCOPIC 1 0.0002
249 HYPOVOLAEMIC SHOCK 1 0.0002
250 SUBCUTANEOUS ABSCESS 1 0.0002
251 STILLBIRTH 1 0.0002
252 ENTEROCOCCAL INFECTION 1 0.0002
253 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
254 THERAPY CHANGE 2 0.0002
255 SKIN HAEMORRHAGE 3 0.0002
256 INFLAMMATORY MARKER INCREASED 1 0.0002
257 ERYSIPELAS 1 0.0002
258 ANKLE FRACTURE 3 0.0002
259 DELUSION 3 0.0002
260 POLLAKIURIA 8 0.0002
261 RESTLESSNESS 7 0.0002
262 SEDATION 5 0.0002
263 AGITATION 14 0.0002
264 RENAL IMPAIRMENT 16 0.0002
265 ANHEDONIA 5 0.0002
266 STRESS FRACTURE 1 0.0002
267 NEPHROPATHY TOXIC 2 0.0002
268 REBOUND EFFECT 2 0.0002
269 HYPERTONIA 1 0.0002
270 MOUTH SWELLING 1 0.0002
271 HYPERHIDROSIS 22 0.0002
272 DEPRESSED MOOD 9 0.0002
273 THIRST 3 0.0002
274 END STAGE RENAL DISEASE 3 0.0002
275 DEPRESSION 37 0.0002
276 ABASIA 4 0.0002
277 THINKING ABNORMAL 3 0.0002
278 AGGRESSION 8 0.0002
279 INCOHERENT 1 0.0002
280 SKIN FISSURES 3 0.0002
281 BALANCE DISORDER 13 0.0002
282 BRONCHIECTASIS 1 0.0001
283 INFARCTION 1 0.0001
284 RESPIRATION ABNORMAL 1 0.0001
285 RHABDOMYOLYSIS 6 0.0001
286 MAJOR DEPRESSION 1 0.0001
287 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
288 ABDOMINAL DISTENSION 14 0.0001
289 HALLUCINATION 10 0.0001
290 SUICIDE ATTEMPT 8 0.0001
291 MEMORY IMPAIRMENT 18 0.0001
292 TINNITUS 6 0.0001
293 DISTURBANCE IN ATTENTION 7 0.0001
294 CONGENITAL ANOMALY 1 0.0001
295 TENDONITIS 2 0.0001
296 CYANOSIS 2 0.0001
297 ANAPHYLACTIC REACTION 7 0.0001
298 PRODUCT PRESCRIBING ERROR 3 0.0001
299 BLOOD POTASSIUM INCREASED 2 0.0001
300 OSTEOPOROSIS 5 0.0001
301 EXTRAPYRAMIDAL DISORDER 3 0.0001
302 EOSINOPHIL COUNT INCREASED 1 0.0001
303 VITAMIN D DECREASED 1 0.0001
304 MYOPATHY 1 0.0001
305 ECZEMA 6 0.0001
306 TREMOR 19 0.0001
307 MUSCLE SPASMS 21 0.0001
308 URINE OUTPUT DECREASED 1 0.0001
309 NEUROTOXICITY 2 0.0001
310 SLEEP DISORDER 8 0.0001
311 HYPERTENSION 24 0.0001
312 BRADYCARDIA 6 0.0001
313 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
314 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
315 HEART RATE INCREASED 11 0.0001
316 MOOD ALTERED 3 0.0001
317 RESTLESS LEGS SYNDROME 2 0.0001
318 INTENTIONAL OVERDOSE 7 0.0001
319 SKIN DISCOLOURATION 5 0.0001
320 GRAND MAL CONVULSION 1 0.0001
321 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
322 PARAESTHESIA 17 0.0001
323 MENTAL STATUS CHANGES 3 0.0001
324 COGNITIVE DISORDER 5 0.0001
325 DEFORMITY 1 0.0001
326 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
327 PAIN IN JAW 3 0.0001
328 MUSCULAR WEAKNESS 12 0.0001
329 SINUS BRADYCARDIA 1 0.0001
330 EAR PAIN 2 0.0001
331 PARKINSONISM 1 0.0001
332 PHARYNGEAL SWELLING 1 0.0001
333 RENAL TUBULAR NECROSIS 1 0.0001
334 BODY TEMPERATURE DECREASED 1 0.0001
335 LIGAMENT SPRAIN 1 0.0001
336 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
337 SALIVARY HYPERSECRETION 1 0.0001
338 LACRIMATION INCREASED 3 0.0001
339 INTENTIONAL SELF-INJURY 2 0.0001
340 DRY MOUTH 8 0.0001
341 NEUTROPHIL COUNT INCREASED 1 0.0001
342 INITIAL INSOMNIA 1 0.0001
343 EAR DISCOMFORT 1 0.0001
344 EXPOSURE DURING PREGNANCY 6 0.0001
345 WITHDRAWAL SYNDROME 4 0.0001
346 TOXICITY TO VARIOUS AGENTS 16 0.0001
347 CYSTITIS 3 0.0001
348 BODY HEIGHT DECREASED 1 0.0001
349 BIPOLAR DISORDER 1 0.0001
350 IMPAIRED HEALING 3 0.0001
351 DRUG WITHDRAWAL SYNDROME 8 0.0001
352 DENTAL CARIES 1 0.0001
353 SYNCOPE 9 0.0001
354 GAIT INABILITY 3 0.0001
355 PANCYTOPENIA 5 0.0001
356 STATUS EPILEPTICUS 1 0.0001
357 PRODUCT AVAILABILITY ISSUE 2 0.0001
358 GASTRIC DISORDER 3 0.0001
359 NIGHTMARE 3 0.0001
360 DELIRIUM 3 0.0001
361 BLOOD CHOLESTEROL INCREASED 4 0.0001
362 COMA 4 0.0001
363 MACULAR DEGENERATION 1 0.0001
364 ACCIDENT 1 0.0001
365 POLYNEUROPATHY 1 0.0001
366 NEURALGIA 2 0.0001
367 MUSCLE SPASTICITY 1 0.0001
368 HYPERCALCAEMIA 1 0.0001
369 HOT FLUSH 6 0.0001
370 POISONING 1 0.0001
371 BRAIN OEDEMA 1 0.0001
372 TACHYCARDIA 7 0.0001
373 MYDRIASIS 1 0.0001
374 ERECTILE DYSFUNCTION 2 0.0001
375 ALOPECIA 15 0.0001
376 HAND DEFORMITY 1 0.0001
377 INSOMNIA 20 0.0001
378 HYPOAESTHESIA 11 0.0001
379 PERIPHERAL COLDNESS 1 0.0001
380 CONTUSION 7 0.0001
381 TREATMENT FAILURE 6 0.0001
382 CARDIO-RESPIRATORY ARREST 3 0.0001
383 SINUS TACHYCARDIA 1 0.0001
384 SUBDURAL HAEMATOMA 1 0.0001
385 PARALYSIS 1 0.0001
386 OVERDOSE 15 0.0001
387 PRODUCT SUBSTITUTION ISSUE 4 0.0001
388 SEIZURE 8 0.0001
389 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
390 INTENTIONAL PRODUCT MISUSE 6 0.0001
391 CARDIOMYOPATHY 1 0.0001
392 HEPATIC FAILURE 2 0.0001
393 APHASIA 2 0.0001
394 DISCOMFORT 4 0.0001
395 VISION BLURRED 9 0.0001
396 SKIN IRRITATION 3 0.0001
397 ACUTE KIDNEY INJURY 10 0.0001
398 LIMB DISCOMFORT 2 0.0001
399 LUNG INFECTION 1 0.0001
400 PRODUCT USE COMPLAINT 1 0.0001
401 OCULAR HYPERAEMIA 3 0.0001
402 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
403 HYPOTHYROIDISM 2 0.0001
404 CONFUSIONAL STATE 10 0.0001
405 VENTRICULAR TACHYCARDIA 1 0.0001
406 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
407 DRUG ABUSE 5 0.0001
408 CIRCULATORY COLLAPSE 1 0.0001
409 EOSINOPHILIA 1 0.0001
410 HEART RATE DECREASED 2 0.0001
411 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
412 HEAD DISCOMFORT 1 0.0001
413 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
414 ANXIETY 16 0.0001
415 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
416 ADVERSE DRUG REACTION 5 0.0001
417 DRUG EFFECT INCOMPLETE 2 0.0001
418 WEIGHT INCREASED 12 0.0001
419 EYE PAIN 3 0.0001
420 CONDITION AGGRAVATED 16 0.0001
421 ERUCTATION 1 0.0001
422 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
423 IRRITABILITY 3 0.0000
424 HYPOTENSION 10 0.0000
425 DRUG DEPENDENCE 8 0.0000
426 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
427 VERTIGO 3 0.0000
428 PULMONARY HYPERTENSION 1 0.0000
429 OSTEOARTHRITIS 2 0.0000
430 MYALGIA 8 0.0000
431 RHINORRHOEA 3 0.0000
432 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
433 BLOOD PRESSURE INCREASED 7 0.0000
434 MUSCULOSKELETAL STIFFNESS 4 0.0000
435 BLOOD PRESSURE DECREASED 3 0.0000
436 GLOSSODYNIA 1 0.0000
437 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
438 ADVERSE EVENT 4 0.0000
439 DISEASE RECURRENCE 2 0.0000
440 CONSTIPATION 9 0.0000
441 ENCEPHALOPATHY 1 0.0000
442 CHRONIC KIDNEY DISEASE 3 0.0000
443 FALL 13 0.0000
444 LOSS OF CONSCIOUSNESS 5 0.0000
445 HEADACHE 24 0.0000
446 NERVOUSNESS 2 0.0000
447 MUCOSAL INFLAMMATION 1 0.0000
448 ASTHENIA 14 0.0000
449 THROAT TIGHTNESS 1 0.0000
450 CARDIAC ARREST 3 0.0000
451 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
452 MEDICATION ERROR 2 0.0000
453 THROMBOCYTOPENIA 4 0.0000
454 HYPONATRAEMIA 2 0.0000
455 CONVULSION 2 0.0000
456 ANGINA PECTORIS 1 0.0000
457 HYPERSOMNIA 1 0.0000
458 PSYCHOTIC DISORDER 1 0.0000
459 THERAPEUTIC RESPONSE DECREASED 2 0.0000
460 ILL-DEFINED DISORDER 2 0.0000
461 DIZZINESS 16 0.0000
462 SWOLLEN TONGUE 1 0.0000
463 NEUROPATHY PERIPHERAL 3 0.0000
464 DRUG INTOLERANCE 3 0.0000
465 NIGHT SWEATS 1 0.0000
466 DYSPEPSIA 3 0.0000
467 LIP SWELLING 1 0.0000
468 FUNGAL INFECTION 1 0.0000
469 URINARY RETENTION 1 0.0000
470 HYPERKALAEMIA 1 0.0000
471 PRODUCT ADHESION ISSUE 1 0.0000
472 CRYING 1 0.0000
473 DYSGEUSIA 2 0.0000
474 UNEVALUABLE EVENT 2 0.0000
475 PALPITATIONS 3 0.0000
476 NAUSEA 20 0.0000
477 ABNORMAL BEHAVIOUR 1 0.0000
478 FEELING ABNORMAL 6 0.0000
479 OEDEMA PERIPHERAL 3 0.0000
480 NEUTROPHIL COUNT DECREASED 1 0.0000
481 DRUG INEFFECTIVE 31 0.0000
482 FATIGUE 18 0.0000
483 MENTAL DISORDER 1 0.0000
484 MYOCARDIAL INFARCTION 4 0.0000
485 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
486 PULMONARY OEDEMA 1 0.0000
487 BACK PAIN 5 0.0000
488 RENAL DISORDER 1 0.0000
489 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
490 OFF LABEL USE 18 0.0000
491 MALAISE 9 0.0000
492 LUNG DISORDER 1 0.0000
493 PAIN IN EXTREMITY 6 0.0000
494 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
495 SINUSITIS 2 0.0000
496 ARTHRALGIA 8 0.0000
497 MUSCULOSKELETAL PAIN 1 0.0000
498 SPEECH DISORDER 1 0.0000
499 PANCREATITIS 1 0.0000
500 OEDEMA 1 0.0000
501 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
502 HAEMATOCHEZIA 1 0.0000
503 SEPSIS 2 0.0000
504 NECK PAIN 1 0.0000
505 OXYGEN SATURATION DECREASED 1 0.0000
506 FLATULENCE 1 0.0000
507 HERPES ZOSTER 1 0.0000
508 LETHARGY 1 0.0000
509 ABDOMINAL PAIN 4 0.0000
510 DYSPHONIA 1 0.0000
511 SURGERY 1 0.0000
512 VOMITING 8 0.0000
513 EMOTIONAL DISTRESS 2 0.0000
514 DYSPNOEA 9 0.0000
515 GAIT DISTURBANCE 3 0.0000
516 PNEUMONIA 5 0.0000
517 AMNESIA 1 0.0000
518 BLOOD CREATININE INCREASED 1 0.0000
519 FEBRILE NEUTROPENIA 1 0.0000
520 RENAL FAILURE 2 0.0000
521 NEOPLASM MALIGNANT 1 0.0000
522 PRODUCT QUALITY ISSUE 2 0.0000
523 BURNING SENSATION 1 0.0000
524 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
525 MOBILITY DECREASED 1 0.0000
526 RESPIRATORY FAILURE 1 0.0000
527 EPISTAXIS 1 0.0000
528 DIARRHOEA 8 0.0000
529 INFLUENZA LIKE ILLNESS 1 0.0000
530 OROPHARYNGEAL PAIN 1 0.0000
531 CHEST PAIN 2 0.0000
532 DYSPHAGIA 1 0.0000
533 PULMONARY EMBOLISM 1 0.0000
534 ATRIAL FIBRILLATION 1 0.0000
535 CHEST DISCOMFORT 1 0.0000
536 HAEMOGLOBIN DECREASED 1 0.0000
537 ILLNESS 1 0.0000
538 HAEMORRHAGE 1 0.0000
539 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
540 INFLUENZA 1 0.0000
541 RHEUMATOID ARTHRITIS 1 0.0000
542 INCORRECT DOSE ADMINISTERED 2 0.0000
543 CHILLS 1 0.0000
544 DISEASE PROGRESSION 1 0.0000
545 PAIN 5 0.0000
546 PRURITUS 3 0.0000
547 WEIGHT DECREASED 2 0.0000
548 INFECTION 1 0.0000
549 URINARY TRACT INFECTION 1 0.0000
550 COVID-19 1 0.0000
551 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
552 NO ADVERSE EVENT 1 0.0000
553 NASOPHARYNGITIS 1 0.0000
554 HYPERSENSITIVITY 1 0.0000
555 BLOOD GLUCOSE INCREASED 1 0.0000
556 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
557 DEATH 4 0.0000
558 DECREASED APPETITE 1 0.0000
559 COUGH 1 0.0000
560 PYREXIA 1 0.0000